Product / procedure: Hyacorp MLF2 – buttock augmentation
Anonymous
十二月 15日, 2025 15:35
Patient description
Total injected volume:
February 2024: 70 cc
July 2024: 70 cc
Patient: Female, healthy, no significant medical history.
Case description
Since August 2024, the patient has been experiencing recurrent inflammatory flares characterized by:
sudden onset erythema,
swelling,
induration,
firm nodules,
and a general malaise-like sensation without fever.
Each flare occurs approximately every 4 weeks, lasts about 7 days, and resolves spontaneously.
The patient reports no correlation with menstrual cycle.
Previous ultrasound examinations (performed earlier this year) revealed multiple small nodules consistent with localized filler deposits. Hyaluronidase was applied at that time with full clinical resolution.
In the current episode, symptoms reappeared again several days ago.
A prednisolone taper previously reduced symptom severity, but flares continued to recur monthly.
Given suspicion of a biofilm-driven delayed inflammatory reaction, the patient was started on doxycycline 100 mg. After several days, no clinical improvement has been observed.
The patient is scheduled for review tomorrow.
Question for the IMCAS community:
What is currently considered the most appropriate next-line intervention?
Thank you in advance to all colleagues for your valuable input and for thinking along with me on this challenging case. Your expertise is greatly appreciated.
Please login to view content
登录
Nikolaus LINDE 医师
皮肤科医师, 瑞士
十二月 15日, 2025 21:55
Anonymous
十二月 16日, 2025 11:19
Ahmed AL QAHTANI
企业代表, 美国
十二月 15日, 2025 21:35
Anonymous
十二月 16日, 2025 11:20
Jameel Ismail SAYED 医师
皮肤科医师, 卡塔尔
十二月 15日, 2025 19:48
Anonymous
十二月 15日, 2025 18:59
Prashant Madhukar MURUGKAR 医师
整形外科医师, 英国
十二月 15日, 2025 18:41
Fadi HAMADANI 医师
整形外科医师, 巴勒斯坦领土
十二月 15日, 2025 17:54
Gurler AKINBINGOL 医师
整形外科医师, 土耳其
十二月 15日, 2025 17:18